Search Results - "Treglia, Giorgio"

[¹⁸F]Fluorocholine PET/CT as First-Line vs. Second-Line Imaging Method to localize parathyroid adenomas in primary hyperparathyroidism: "Game, Set, and Match".

Authors: Treglia, Giorgio Piccardo, Arnoldo Paone, Gaetano et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2024, Vol. 51 Issue 12, p3596-3599. 4p.

In Vivo Versus In Vitro Somatostatin Receptor Expression in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Correlation Studies.

Authors: Perrone, Elisabetta Treglia, Giorgio Giancipoli, Romina Grazia et al.

Source: International Journal of Molecular Sciences. Jul2025, Vol. 26 Issue 14, p6551. 16p.

Expanding the clinical indications of [¹⁸F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded.

Authors: Treglia, Giorgio Rizzo, Alessio Piccardo, Arnoldo

Source: European Journal of Nuclear Medicine & Molecular Imaging. Apr2024, Vol. 51 Issue 5, p1345-1348. 4p.

Prevalence of Incidental Findings Suspicious for Transthyretin Cardiac Amyloidosis among Patients Undergoing Bone Scintigraphy: A Systematic Review and a Meta-Analysis.

Authors: Treglia, Giorgio Martinello, Chiara Dondi, Francesco et al.

Source: Journal of Clinical Medicine. Sep2023, Vol. 12 Issue 17, p5698. 13p.

Performance of [ 18 F]FDG PET/CT in Diagnosing Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and a Bivariate Meta-Analysis.

Authors: Treglia, Giorgio Albano, Domenico Rizzo, Alessio et al.

Source: Diagnostics (2075-4418). Aug2024, Vol. 14 Issue 15, p1603. 14p.

Correction: Iacovitti et al. The Prevalence and Malignancy Risk of Breast Incidental Uptake Detected by PET/CT with Different Radiopharmaceuticals: An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2025, 18 , 1831.

Authors: Iacovitti, Cesare Michele Marin, Andreea Tasevski, Slavko et al.

Source: Pharmaceuticals (14248247). Jan2026, Vol. 19 Issue 1, p112. 2p.

Multimodality Imaging and Immune‐Related Adverse Events During Immune Checkpoint Inhibitors Treatment: Where Do We Stand?

Authors: Crosio, Stephanie Treglia, Giorgio Imbimbo, Martina et al.

Source: Echocardiography. Mar2025, Vol. 42 Issue 3, p1-11. 11p.

EANM/SNMMI guideline/procedure standard for [¹⁸F]FDG hybrid PET use in infection and inflammation in adults v2.0.

Authors: Abikhzer, Gad Treglia, Giorgio Pelletier-Galarneau, Matthieu et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jan2025, Vol. 52 Issue 2, p510-538. 29p.

Treatment response assessment in transthyretin-related cardiac amyloidosis: an emerging clinical indication of bone-seeking radiopharmaceuticals?

Authors: Gheysens, Olivier Treglia, Giorgio Masri, Ahmad et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Feb2024, Vol. 51 Issue 3, p691-694. 4p.

The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy.

Authors: Piccardo, Arnoldo Treglia, Giorgio Fiz, Francesco et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Feb2024, Vol. 51 Issue 3, p756-767. 12p.

What Is the Role of [¹⁸F]FDG PET/CT in the "Recommendations for Updating Fever and Inflammation of Unknown Origin From a Modified Delphi Consensus Panel" by Wright et al?

Authors: Albano, Domenico Treglia, Giorgio

Source: Open Forum Infectious Diseases. Oct2024, Vol. 11 Issue 10, p1-2. 2p.

A systematic review for the evidence of recommendations and guidelines in hybrid nuclear cardiovascular imaging.

Authors: Besson, Florent L. Treglia, Giorgio Bucerius, Jan et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2024, Vol. 51 Issue 8, p2247-2259. 13p.

"Not All That Glitters Is Gold": Paraspinal Cavernous Hemangioma Mimicking Paraganglioma on Somatostatin Receptor PET/CT.

Authors: Iacovitti, Cesare Michele Cabrilo, Ivan Martinello, Chiara et al.

Source: Diagnostics (2075-4418). Oct2025, Vol. 15 Issue 19, p2456. 3p.

18 F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?

Authors: Albano, Domenico Treglia, Giorgio Dondi, Francesco et al.

Source: Cancers. May2023, Vol. 15 Issue 9, p2494. 12p.

[¹⁸F]FDG WBC labelled PET/CT for the diagnosis of infectious disease: initial experience in a tertiary centre.

Authors: Kamani, Christel Hermann Costes, Julien Panchaud, Maxime et al.

Source: EJNMMI Research. 4/7/2026, Vol. 16 Issue 1, p1-11. 11p.

Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis.

Authors: Muoio, Barbara Iacovitti, Cesare Michele Bosetti, Davide Giovanni et al.

Source: Cancers. Jun2025, Vol. 17 Issue 12, p2039. 13p.

Enhanced staging of differentiated thyroid carcinoma: integrating [¹⁸F]FDG digital PET/CT with neck ultrasound.

Authors: Piccardo, Arnoldo Bottoni, Gianluca Treglia, Giorgio et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2025, Vol. 52 Issue 8, p2875-2886. 12p.

Nuclear medicine practice in the field of infection and inflammation imaging: a pragmatical survey.

Authors: Annunziata, Salvatore Treglia, Giorgio Jamar, Francois et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2022, Vol. 49 Issue 7, p2113-2119. 7p. 5 Graphs.

FAPI PET/CT in infectious, inflammatory, and rheumatological diseases: "watch it like a hawk" or "one swallow does not make a summer"?

Authors: Treglia, Giorgio Albano, Domenico

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2023, Vol. 50 Issue 7, p1848-1850. 3p. 1 Chart.

Gastric Adenocarcinoma Incidentally Detected by PET/CT with PSMA Ligands.

Authors: Iacovitti, Cesare Michele Muoio, Barbara Cuzzocrea, Marco et al.

Source: Diagnostics (2075-4418). Jan2025, Vol. 15 Issue 1, p101. 3p.